… -chemotherapy (RT-CHX) has been shown to improve overall survival (OS) compared to …
chemotherapy with cisplatin and 5 FU in locally advanced squamous cell carcinoma of the head …

… cell carcinoma of the head and neck (SCCHN) accounts for more than 90% of cases of head
and … status, but treatment usually consists of palliative chemotherapy. In a few cases, re-…

… survival of reirradiated patients marginally exceeds that of chemotherapy alone. However,
the 2–3-… with nonmetastatic squamous cell cancer undergoing concurrent chemotherapy and …

… Former meta-analyses have shown a survival benefit for the addition of chemotherapy (CHX…
AFRT) in locally advanced squamous cell carcinoma (SCC) of the head and neck. However, …

… of induction chemotherapy in patients with resectable head and neck squamous cell carcinoma.
… Based on the results above, there is a significant benefit of induction chemotherapy on …

… in primary head and neck squamous cell carcinoma (HNSCC… cisplatin-fluorouracil neoadjuvant
chemotherapy. p53 status … and response to neoadjuvant chemotherapy. Results: Exons …

… the chemotherapeutic management of patients with squamous cell carcinoma of the head
and … Combination chemotherapy has resulted in a high proportion of objective respondersand …

… resectable squamous cell carcinomas of the head and neck. Patients were staged according
to the 1980 guidelines of the American Joint Committee (AJC) Staging System for head and …

… chemotherapy regimens in combination with radiation for primary treatment of non-nasopharyngeal
squamous cell … , are considerably different in chemotherapeutic agents and treatment …

PURPOSE Two consecutive randomized trials were run at our institution using the bioreductive
alkylating agent mitomycin as an adjunct to radiation therapy in an effort to improve …